Overview
Miki Nishitani is a Pediatrics specialist and a Hematologist in Boston, Massachusetts. Dr. Nishitani is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Hepatic Venoocclusive Disease with Immunodeficiency, Acute Lymphoblastic Leukemia (ALL), Virus Associated Hemophagocytic Syndrome, and Hemophagocytic Lymphohistiocytosis. Dr. Nishitani is currently accepting new patients.
Her clinical research consists of co-authoring 7 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Corey Cutler is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Cutler is rated as an Elite provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. Cutler is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Eric Winer is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Winer is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Winer is currently accepting new patients.
The General Hospital Corporation
Philip Amrein is an Oncologist in Boston, Massachusetts. Dr. Amrein is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Amrein is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hepatic Venoocclusive Disease with Immunodeficiency
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Nishitani isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Nishitani isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Nishitani isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adrenal CancerDr. Nishitani isExperienced. Learn about Adrenal Cancer.
- Childhood Acute Myeloid LeukemiaDr. Nishitani isExperienced. Learn about Childhood Acute Myeloid Leukemia.